113 related articles for article (PubMed ID: 38420804)
1. A Comprehensive Prognostic and Immune Infiltration Analysis of RBM4 in Pan-Cancer.
Ding JJ; Wu J; Bian HL; Zong Y; Lu B; Ni L
Front Biosci (Landmark Ed); 2024 Feb; 29(2):89. PubMed ID: 38420804
[TBL] [Abstract][Full Text] [Related]
2. RBM4 modulates the proliferation and expression of inflammatory factors via the alternative splicing of regulatory factors in HeLa cells.
Wang WY; Quan W; Yang F; Wei YX; Chen JJ; Yu H; Xie J; Zhang Y; Li ZF
Mol Genet Genomics; 2020 Jan; 295(1):95-106. PubMed ID: 31489484
[TBL] [Abstract][Full Text] [Related]
3. NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation.
Wang Q; Li Z; Zhou S; Li Z; Huang X; He Y; Zhang Y; Zhao X; Tang Y; Xu M
Front Immunol; 2023; 14():1097403. PubMed ID: 36776838
[TBL] [Abstract][Full Text] [Related]
4. Nuclear Aurora kinase A switches m
Li S; Qi Y; Yu J; Hao Y; He B; Zhang M; Dai Z; Jiang T; Li S; Huang F; Chen N; Wang J; Yang M; Liang D; An F; Zhao J; Fan W; Pan Y; Deng Z; Luo Y; Guo T; Peng F; Hou Z; Wang C; Zheng F; Xu L; Xu J; Wen Q; Jin B; Wang Y; Liu Q
Signal Transduct Target Ther; 2022 Apr; 7(1):97. PubMed ID: 35361747
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome-wide targets of alternative splicing by RBM4 and possible role in cancer.
Markus MA; Yang YH; Morris BJ
Genomics; 2016 Apr; 107(4):138-44. PubMed ID: 26898347
[TBL] [Abstract][Full Text] [Related]
6. RNA-Binding Motif 4 (RBM4) Suppresses Tumor Growth and Metastasis in Human Gastric Cancer.
Yong H; Zhao W; Zhou X; Liu Z; Tang Q; Shi H; Cheng R; Zhang X; Qiu Z; Zhu J; Feng Z
Med Sci Monit; 2019 May; 25():4025-4034. PubMed ID: 31145716
[TBL] [Abstract][Full Text] [Related]
7. The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.
Wang Y; Chen D; Qian H; Tsai YS; Shao S; Liu Q; Dominguez D; Wang Z
Cancer Cell; 2014 Sep; 26(3):374-389. PubMed ID: 25203323
[TBL] [Abstract][Full Text] [Related]
8. RBM4 interacts with an intronic element and stimulates tau exon 10 inclusion.
Kar A; Havlioglu N; Tarn WY; Wu JY
J Biol Chem; 2006 Aug; 281(34):24479-88. PubMed ID: 16777844
[TBL] [Abstract][Full Text] [Related]
9. Phylogenetic and molecular characterization of the splicing factor RBM4.
Lu CC; Chen TH; Wu JR; Chen HH; Yu HY; Tarn WY
PLoS One; 2013; 8(3):e59092. PubMed ID: 23527094
[TBL] [Abstract][Full Text] [Related]
10. Natural antisense transcript TPM1-AS regulates the alternative splicing of tropomyosin I through an interaction with RNA-binding motif protein 4.
Huang GW; Zhang YL; Liao LD; Li EM; Xu LY
Int J Biochem Cell Biol; 2017 Sep; 90():59-67. PubMed ID: 28754317
[TBL] [Abstract][Full Text] [Related]
11. Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events.
Lin JC; Lin CY; Tarn WY; Li FY
RNA; 2014 Oct; 20(10):1621-31. PubMed ID: 25140042
[TBL] [Abstract][Full Text] [Related]
12. RBM4 promotes pancreas cell differentiation and insulin expression.
Lin JC; Yan YT; Hsieh WK; Peng PJ; Su CH; Tarn WY
Mol Cell Biol; 2013 Jan; 33(2):319-27. PubMed ID: 23129807
[TBL] [Abstract][Full Text] [Related]
13. Functional pre- mRNA trans-splicing of coactivator CoAA and corepressor RBM4 during stem/progenitor cell differentiation.
Brooks YS; Wang G; Yang Z; Smith KK; Bieberich E; Ko L
J Biol Chem; 2009 Jul; 284(27):18033-46. PubMed ID: 19416963
[TBL] [Abstract][Full Text] [Related]
14. RBM4 regulates cellular senescence via miR1244/SERPINE1 axis.
Wang L; Zhang X; Sheng J; Chen L; Zhi L; Zheng Q; Qi Y; Wang L; Zhang J; Zhao J; Wang Y; Liu SX; Sun MZ; Zhang W
Cell Death Dis; 2023 Jan; 14(1):27. PubMed ID: 36639375
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of decreased expression of RBM4 in human gastric cancer.
Yong H; Zhu H; Zhang S; Zhao W; Wang W; Chen C; Ding G; Zhu L; Zhu Z; Liu H; Zhang Y; Wen J; Kang X; Zhu J; Feng Z; Liu B
Sci Rep; 2016 Jun; 6():28222. PubMed ID: 27324405
[TBL] [Abstract][Full Text] [Related]
16. WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo.
Markus MA; Heinrich B; Raitskin O; Adams DJ; Mangs H; Goy C; Ladomery M; Sperling R; Stamm S; Morris BJ
Exp Cell Res; 2006 Oct; 312(17):3379-88. PubMed ID: 16934801
[TBL] [Abstract][Full Text] [Related]
17. Systematic pan-cancer analysis identifies RBM39 as an immunological and prognostic biomarker.
Zhang R; Wang W; Zhang N; Chen X; Liu W; Zhang L; Liu N
J Cell Mol Med; 2022 Sep; 26(18):4859-4871. PubMed ID: 35989423
[TBL] [Abstract][Full Text] [Related]
18. RBM4 Modulates Radial Migration via Alternative Splicing of Dab1 during Cortex Development.
D D; Hung KY; Tarn WY
Mol Cell Biol; 2018 Jun; 38(12):. PubMed ID: 29581187
[TBL] [Abstract][Full Text] [Related]
19. RBM4 Regulates Neuronal Differentiation of Mesenchymal Stem Cells by Modulating Alternative Splicing of Pyruvate Kinase M.
Su CH; Hung KY; Hung SC; Tarn WY
Mol Cell Biol; 2017 Feb; 37(3):. PubMed ID: 27821480
[TBL] [Abstract][Full Text] [Related]
20. Landscape of Alternative Splicing Events Related to Prognosis and Immune Infiltration in Glioma: A Data Analysis and Basic Verification.
Su HX; Yang G; Su F; Hu CX; Zhang T; Ran JT; Guan QL
J Immunol Res; 2022; 2022():2671891. PubMed ID: 35832652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
